Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes
Shares in biotech Valneva ($VALN) soared over 20% in early trading today after it and partner Pfizer ($PFE) as it moved closer to bringing its Lyme...
Valneva Se (VALN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 763,199 | $3,991,531 | 0.36% | |
| 2. | Millennium Management Israel Englander | 135,223 | $707,216 | 0% | |
| 3. | Ironwood Investment Management Warren Isabelle | 45,064 | $235,685 | +80% | 0.08% |
| 4. | Citadel Investment Group Ken Griffin | 20,294 | $106,138 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,291,666 | $11,985,413 | 0.26% | |
| 2. | 354,361 | $1,853,308 | 0.11% | |
| 3. | 77,214 | $403,829 | 0% | |
| 4. | 56,217 | $294,014 | 0% | |
| 5. | 15,178 | $79,381 | 0% |
News See All
Valneva SE (NASDAQ:VALN) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Valneva presents its First Quarter 2026 Financial Results. [Operator Instructions] Please be advised that today's conference is being recorded.
Guggenheim Cuts PT on Valneva SE (VALN) to $11 From $13
Valneva SE (NASDAQ:VALN) is one of the most undervalued biotech stocks to buy right now. Guggenheim cut the price target on Valneva SE (NASDAQ:VALN) to $11 from $13 on April 16, reiterating a Buy rating...
8 Most Undervalued Biotech Stocks to Buy Right Now
On April 13, Tom Lee, Fundstrat's head of research, appeared on CNBC’s 'Power Lunch' to talk about his outlook on equities, what to expect in a wartime economy, and more.
8 Most Oversold Strong Buy-Rated Stocks to Invest In
Oversold stocks are getting a fresh look in 2026, but not simply because they are down.
Valneva SE (NASDAQ:VALN) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Valneva 9 Months 2025 Financial Results Conference Call and Webcast.
Valneva SE (NASDAQ:VALN) Q2 2025 Earnings Call Transcript
Joshua Drumm: Thank you, operator. Hello, and thank you for joining us to discuss Valneva's first half 2025 results and corporate update. It's my pleasure to welcome you today.
Valneva SE (NASDAQ:VALN) Q1 2025 Earnings Call Transcript
Joshua Drumm: Thank you. Hello, and thank you for joining us to discuss Valneva's first quarter 2025 results and corporate update. It's my pleasure to welcome you today.
11 Best Performing NASDAQ Stocks So Far in 2025
On March 29, T. Rowe Price portfolio manager Tony Wang appeared on CNBC’s 'Closing Bell Overtime' to discuss the current volatility in the tech sector, especially the NASDAQ.
Valneva SE (NASDAQ:VALN) Q4 2024 Earnings Call Transcript
Joshua Drumm: Thank you. Hello, and thank you for joining us to discuss Valneva’s Full Year 2024 Results and Corporate Update. It’s my pleasure to welcome you today.